You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel debates lower-dose Moderna COVID booster

U.S. health advisers are debating if those who received Moderna COVID-19 vaccinations should get a booster at half the original dosage. But they stress the priority is still to get shots to the 66 million unvaccinated Americans who are eligible. (Oct. 14)
image beaconimage beaconimage beacon